Delivery Order SPE2DB20D9127-SPE2DB25FPPH2

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Jakafi 10 mg tablets, a prescription medication, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 60 units of the prescription drug Jakafi 15 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $499,999,999 between DMS Pharmaceutical Group and the DLA, which covers a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, provides for the delivery of Jakafi 15 mg tablets to support the medical supply needs of U.S. government agencies, particularly the Department of Defense. This Delivery Order is issued under DMS Pharmaceutical Group's...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $35,321.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the medication Jakafi 15 mg tablets, with a completion date of August 15, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,300.73 contract is to provide the DLA with 4,556,044,091 units of the drug Jakafi 10 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue firm fixed-price orders for a...
The Defense Logistics Agency (DLA) awarded a $23,681.32 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Jakafi 10 mg tablet medical products. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items, including...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $47,362.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,373 units of the branded prescription drug Jakafi 10 mg tablets. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which provides a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60 units of the 5 mg tablet form of the pharmaceutical product JAKAFI. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $23,699.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4566582308 - JAKAFI 5 MG TABLET 60S, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,565,106,523 units of the prescription drug Jakafi 15 mg tablet. This order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPPH2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order, valued at $23,699.64, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of Jakafi 5 mg tablets, a branded prescription medication, to support the recurring medical needs of military healthcare facilities. This award is issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency to place orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across various medical product categories.

Generated 2/27/25, 9:42 AM